Most de-identification programs have been built for structured records, which make up only 10-20% of health data. Health insurance claims, lab test results, and prescription dispensing information are…

Recent announcements across the life sciences industry, including new patient-anchored data initiatives, have brought attention to an important question: when companies invest in real-world data (RWD), what actually…

As Datavant builds the agentic AI platform to accelerate the path from data to trusted evidence for Life Sciences organizations, it is critical not only to consider what…

Most Expert Determinations are not shaped by statistical analysis alone. They are also shaped by factors beyond the dataset, including how the data will be used, who can…

Introduction Veterans in the United States shouldn’t have to worry about the privacy of their health data. Between data breaches of the Veterans Health Administration and CPAP Medical…

Life Sciences organizations face growing pressure to generate real-world evidence (RWE) faster and at greater scale-for internal decision-making, publication, and external stakeholders, including regulators and payers.Speed is now…

Life Sciences is at an inflection point. Real-world data (RWD) and AI have progressed from pilot programs and proof-of-concept experimentation to core components of clinical development and evidence…

I. The Persistent Execution Gap in RWE Generation in Clinical Development We have previously articulated the case for systematic, integrated RWE generation beginning early in drug development -…